Arthur M. Krieg, SVP, R & D, Chief Scien. Officer at Coley Pharmaceutical Group, Inc. (COLY), sold 18,422 shares at $2.24 ($41K) on 2006-12-07, disclosed to the SEC on 2006-12-11.
Open-market sale of $41k COLY by SVP, R & D, Chief Scien. Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Something here stands out, but not much.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $0.00 | 300 | $0 | 0.0% |
| 2 | $2.24 | 18,122 | $41K | 100.0% |
| Total | $2.20 avg | 18,422 | $41K | 100% |
| Filing → |
| CMPI | BUY | 2021-05-19 | $349K | — | Filing → |
| CMPI | BUY | 2021-03-31 | $741K | — | Filing → |
| CMPI | BUY | 2021-03-29 | $290K | — | Filing → |